Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LNSR
#3130
LENSAR, Inc. Common Stock
11.9
7
-0.66%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.66%
Monthly Change
-3.86%
6 month change
-1.89%
Cambio anual
+7.55%
Cierres anteriores
12.0
5
Open
11.9
7
Bid
Ask
Low
11.9
7
High
11.9
7
Volumen
17
Markets
Acciones
Atención Sanitaria
LNSR
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
-3.15 M
-3.66 M
6.94 M
5 M
3.51 M
11.79 M
Cash from investing activities
905 K
-1.99 M
531 K
6.43 M
-4 M
969 K
Cash from financing activities
93 K
-16 K
9.69 M
93 K
0
9.77 M
Free cash flow
-3.17 M
-3.66 M
6.93 M
4.92 M
3.51 M
11.71 M
Noticias
LENSAR与Alcon交易完成时间推迟至2026年上半年
LENSAR-Alcon deal closing pushed to first half of 2026
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)
LENSARQ3每股收益及营收逊于预期
LENSAR earnings missed by $0.26, revenue fell short of estimates
LENSAR earnings missed by $0.08, revenue fell short of estimates
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)
Alcon: A Clear Vision, But Fully Valued (NYSE:ALC)
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - LENSAR (NASDAQ:LNSR), Alcon (NYSE:ALC)
LENSAR stock surges 23.7% as Q4 revenue beats estimates